TY - JOUR AU - Dienstag, J. L. PY - 2008 DA - 2008// TI - Hepatitis B virus infection JO - N Engl J Med. VL - 359 UR - https://doi.org/10.1056/nejmra0801644 DO - 10.1056/nejmra0801644 ID - Dienstag2008 ER - TY - JOUR AU - Janssen, H. L. AU - van Zonneveld, M. AU - Senturk, H. AU - Zeuzem, S. AU - Akarca, U. S. AU - Cakaloglu, Y. PY - 2005 DA - 2005// TI - Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial JO - Lancet. VL - 365 UR - https://doi.org/10.1016/s0140-6736(05)17701-0 DO - 10.1016/s0140-6736(05)17701-0 ID - Janssen2005 ER - TY - JOUR AU - Chang, T. T. AU - Gish, R. G. AU - de Man, R. AU - Gadano, A. AU - Sollano, J. AU - Chao, Y. C. PY - 2006 DA - 2006// TI - A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B JO - N Engl J Med. VL - 354 UR - https://doi.org/10.1056/nejmoa051285 DO - 10.1056/nejmoa051285 ID - Chang2006 ER - TY - JOUR AU - Perrillo, R. PY - 2009 DA - 2009// TI - Benefits and risks of interferon therapy for hepatitis B JO - Hepatology. VL - 49 UR - https://doi.org/10.1002/hep.22956 DO - 10.1002/hep.22956 ID - Perrillo2009 ER - TY - JOUR AU - Hu, J. AU - Protzer, U. AU - Siddiqui, A. PY - 2019 DA - 2019// TI - Revisiting hepatitis B virus: challenges of curative therapies JO - J Virol. UR - https://doi.org/10.1128/jvi.01032-19 DO - 10.1128/jvi.01032-19 ID - Hu2019 ER - TY - JOUR AU - Protzer, U. AU - Maini, M. K. AU - Knolle, P. A. PY - 2012 DA - 2012// TI - Living in the liver: hepatic infections JO - Nat Rev Immunol. VL - 12 UR - https://doi.org/10.1038/nri3169 DO - 10.1038/nri3169 ID - Protzer2012 ER - TY - JOUR AU - Vandepapeliere, P. AU - Lau, G. K. AU - Leroux-Roels, G. AU - Horsmans, Y. AU - Gane, E. AU - Tawandee, T. PY - 2007 DA - 2007// TI - Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine JO - Vaccine. VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.09.072 DO - 10.1016/j.vaccine.2007.09.072 ID - Vandepapeliere2007 ER - TY - JOUR AU - Xu, D. Z. AU - Wang, X. Y. AU - Shen, X. L. AU - Gong, G. Z. AU - Ren, H. AU - Guo, L. M. PY - 2013 DA - 2013// TI - Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings JO - J Hepatol. VL - 59 UR - https://doi.org/10.1016/j.jhep.2013.05.003 DO - 10.1016/j.jhep.2013.05.003 ID - Xu2013 ER - TY - JOUR AU - Depla, E. AU - Aa, A. AU - Livingston, B. D. AU - Crimi, C. AU - Allosery, K. AU - Brabandere, V. PY - 2008 DA - 2008// TI - Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections JO - J Virol. VL - 82 UR - https://doi.org/10.1128/jvi.01505-07 DO - 10.1128/jvi.01505-07 ID - Depla2008 ER - TY - JOUR AU - Janssens, S. AU - Beyaert, R. PY - 2003 DA - 2003// TI - Role of Toll-like receptors in pathogen recognition JO - Clin Microbiol Rev. VL - 16 UR - https://doi.org/10.1128/CMR.16.4.637-646.2003 DO - 10.1128/CMR.16.4.637-646.2003 ID - Janssens2003 ER - TY - JOUR AU - Galluzzi, L. AU - Vacchelli, E. AU - Eggermont, A. AU - Fridman, W. H. AU - Galon, J. AU - Sautes-Fridman, C. PY - 2012 DA - 2012// TI - Trial Watch: experimental Toll-like receptor agonists for cancer therapy JO - Oncoimmunology. VL - 1 UR - https://doi.org/10.4161/onci.20696 DO - 10.4161/onci.20696 ID - Galluzzi2012 ER - TY - JOUR AU - Kosinska, A. D. AU - Moeed, A. AU - Kallin, N. AU - Festag, J. AU - Su, J. AU - Steiger, K. PY - 2019 DA - 2019// TI - Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection JO - Sci Rep. VL - 9 UR - https://doi.org/10.1038/s41598-019-47149-w DO - 10.1038/s41598-019-47149-w ID - Kosinska2019 ER - TY - JOUR AU - Lanford, R. E. AU - Guerra, B. AU - Chavez, D. AU - Giavedoni, L. AU - Hodara, V. L. AU - Brasky, K. M. PY - 2013 DA - 2013// TI - GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees JO - Gastroenterology. VL - 144 UR - https://doi.org/10.1053/j.gastro.2013.02.003 DO - 10.1053/j.gastro.2013.02.003 ID - Lanford2013 ER - TY - JOUR AU - Borducchi, E. N. AU - Cabral, C. AU - Stephenson, K. E. AU - Liu, J. AU - Abbink, P. AU - Ng’ang’a, D. PY - 2016 DA - 2016// TI - Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys JO - Nature. VL - 540 UR - https://doi.org/10.1038/nature20583 DO - 10.1038/nature20583 ID - Borducchi2016 ER - TY - JOUR AU - Bagnoli, F. AU - Fontana, M. R. AU - Soldaini, E. AU - Mishra, R. P. AU - Fiaschi, L. AU - Cartocci, E. PY - 2015 DA - 2015// TI - Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus JO - Proc Natl Acad Sci U S A. VL - 112 UR - https://doi.org/10.1073/pnas.1424924112 DO - 10.1073/pnas.1424924112 ID - Bagnoli2015 ER - TY - JOUR AU - Wille-Reece, U. AU - Wu, C. Y. AU - Flynn, B. J. AU - Kedl, R. M. AU - Seder, R. A. PY - 2005 DA - 2005// TI - Immunization with HIV-1 gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses JO - J Immunol. VL - 174 UR - https://doi.org/10.4049/jimmunol.174.12.7676 DO - 10.4049/jimmunol.174.12.7676 ID - Wille-Reece2005 ER - TY - JOUR AU - Zhao, K. AU - Wang, H. AU - Wu, C. PY - 2011 DA - 2011// TI - The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, polyi: c and R848 JO - Vaccine. VL - 29 UR - https://doi.org/10.1016/j.vaccine.2011.06.100 DO - 10.1016/j.vaccine.2011.06.100 ID - Zhao2011 ER - TY - JOUR AU - Soria, I. AU - Myhre, P. AU - Horton, V. AU - Ellefson, P. AU - McCarville, S. AU - Schmitt, K. PY - 2000 DA - 2000// TI - Effect of food on the pharmacokinetics and bioavailability of oral imiquimod relative to a subcutaneous dose JO - Int J Clin Pharmacol Ther VL - 38 UR - https://doi.org/10.5414/CPP38476 DO - 10.5414/CPP38476 ID - Soria2000 ER - TY - STD TI - Graupe M, Halcomb RL. Purine derivatives and their use as modulators of toll-like receptor 7. 2016. ID - ref19 ER - TY - JOUR AU - Hayashi, T. AU - Rao, S. P. AU - Takabayashi, K. AU - Uden, J. H. AU - Kornbluth, R. S. AU - Baird, S. M. PY - 2001 DA - 2001// TI - Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase JO - Infect Immun VL - 69 UR - https://doi.org/10.1128/IAI.69.10.6156-6164.2001 DO - 10.1128/IAI.69.10.6156-6164.2001 ID - Hayashi2001 ER - TY - JOUR AU - Wu, C. C. AU - Lee, J. AU - Raz, E. AU - Corr, M. AU - Carson, D. A. PY - 2004 DA - 2004// TI - Necessity of oligonucleotide aggregation for toll-like receptor 9 activation JO - J Biol Chem. VL - 279 UR - https://doi.org/10.1074/jbc.M311662200 DO - 10.1074/jbc.M311662200 ID - Wu2004 ER - TY - JOUR AU - Wu, C. C. AU - Hayashi, T. AU - Takabayashi, K. AU - Sabet, M. AU - Smee, D. F. AU - Guiney, D. D. PY - 2007 DA - 2007// TI - Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand JO - Proc Natl Acad Sci U S A. VL - 104 UR - https://doi.org/10.1073/pnas.0611624104 DO - 10.1073/pnas.0611624104 ID - Wu2007 ER - TY - JOUR AU - Cho, H. J. AU - Takabayashi, K. AU - Cheng, P. M. AU - Nguyen, M. D. AU - Corr, M. AU - Tuck, S. PY - 2000 DA - 2000// TI - Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism JO - Nat Biotechnol VL - 18 UR - https://doi.org/10.1038/75365 DO - 10.1038/75365 ID - Cho2000 ER - TY - JOUR AU - Schoggins, J. W. AU - Wilson, S. J. AU - Panis, M. AU - Murphy, M. Y. AU - Jones, C. T. AU - Bieniasz, P. PY - 2011 DA - 2011// TI - A diverse range of gene products are effectors of the type I interferon antiviral response JO - Nature. VL - 472 UR - https://doi.org/10.1038/nature09907 DO - 10.1038/nature09907 ID - Schoggins2011 ER - TY - JOUR AU - Fox, C. B. AU - Orr, M. T. AU - van Hoeven, N. AU - Parker, S. C. AU - Mikasa, T. J. AU - Phan, T. PY - 2016 DA - 2016// TI - Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: a formulation approach JO - J Control Release. VL - 244 UR - https://doi.org/10.1016/j.jconrel.2016.11.011 DO - 10.1016/j.jconrel.2016.11.011 ID - Fox2016 ER - TY - JOUR AU - Smirnov, D. AU - Schmidt, J. J. AU - Capecchi, J. T. AU - Wightman, P. D. PY - 2011 DA - 2011// TI - Vaccine adjuvant activity of 3 M-052: an imidazoquinoline designed for local activity without systemic cytokine induction JO - Vaccine. VL - 29 UR - https://doi.org/10.1016/j.vaccine.2011.05.061 DO - 10.1016/j.vaccine.2011.05.061 ID - Smirnov2011 ER - TY - JOUR AU - Buonsanti, C. AU - Balocchi, C. AU - Harfouche, C. AU - Corrente, F. AU - Galli Stampino, L. AU - Mancini, F. PY - 2016 DA - 2016// TI - Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines JO - Sci Rep. VL - 6 UR - https://doi.org/10.1038/srep29063 DO - 10.1038/srep29063 ID - Buonsanti2016 ER - TY - JOUR AU - Singh, M. AU - Khong, H. AU - Dai, Z. AU - Huang, X. F. AU - Wargo, J. A. AU - Cooper, Z. A. PY - 2014 DA - 2014// TI - Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation JO - J Immunol. VL - 193 UR - https://doi.org/10.4049/jimmunol.1401160 DO - 10.4049/jimmunol.1401160 ID - Singh2014 ER - TY - JOUR AU - Utzschneider, D. T. AU - Alfei, F. AU - Roelli, P. AU - Barras, D. AU - Chennupati, V. AU - Darbre, S. PY - 2016 DA - 2016// TI - High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survival JO - J Exp Med. VL - 213 UR - https://doi.org/10.1084/jem.20150598 DO - 10.1084/jem.20150598 ID - Utzschneider2016 ER - TY - JOUR AU - Yang, D. AU - Liu, L. AU - Zhu, D. AU - Peng, H. AU - Su, L. AU - Fu, Y. X. PY - 2014 DA - 2014// TI - A mouse model for HBV immunotolerance and immunotherapy JO - Cell Mol Immunol. VL - 11 UR - https://doi.org/10.1038/cmi.2013.43 DO - 10.1038/cmi.2013.43 ID - Yang2014 ER - TY - JOUR AU - Czarniecki, M. PY - 2008 DA - 2008// TI - Small molecule modulators of toll-like receptors JO - J Med Chem VL - 51 UR - https://doi.org/10.1021/jm800957k DO - 10.1021/jm800957k ID - Czarniecki2008 ER - TY - JOUR AU - Hood, J. D. AU - Warshakoon, H. J. AU - Kimbrell, M. R. AU - Shukla, N. M. AU - Malladi, S. S. AU - Wang, X. PY - 2010 DA - 2010// TI - Immunoprofiling toll-like receptor ligands: comparison of immunostimulatory and proinflammatory profiles in ex vivo human blood models JO - Hum Vaccines. VL - 6 UR - https://doi.org/10.4161/hv.6.4.10866 DO - 10.4161/hv.6.4.10866 ID - Hood2010 ER - TY - JOUR AU - Coffman, R. L. AU - Sher, A. AU - Seder, R. A. PY - 2010 DA - 2010// TI - Vaccine adjuvants: putting innate immunity to work JO - Immunity VL - 33 UR - https://doi.org/10.1016/j.immuni.2010.10.002 DO - 10.1016/j.immuni.2010.10.002 ID - Coffman2010 ER - TY - JOUR AU - Zhu, J. AU - He, S. AU - Du, J. AU - Wang, Z. AU - Li, W. AU - Chen, X. PY - 2015 DA - 2015// TI - Local administration of a novel Toll-like receptor 7 agonist in combination with doxorubicin induces durable tumouricidal effects in a murine model of T cell lymphoma JO - J Hematol Oncol. VL - 8 UR - https://doi.org/10.1186/s13045-015-0121-9 DO - 10.1186/s13045-015-0121-9 ID - Zhu2015 ER - TY - JOUR AU - Oh, J. Z. AU - Kedl, R. M. PY - 2010 DA - 2010// TI - The capacity to induce cross-presentation dictates the success of a TLR7 agonist-conjugate vaccine for eliciting cellular immunity JO - J Immunol. VL - 185 UR - https://doi.org/10.4049/jimmunol.1001892 DO - 10.4049/jimmunol.1001892 ID - Oh2010 ER - TY - JOUR AU - Kastenmuller, K. AU - Wille-Reece, U. AU - Lindsay, R. W. AU - Trager, L. R. AU - Darrah, P. A. AU - Flynn, B. J. PY - 2011 DA - 2011// TI - Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets JO - J Clin Investig VL - 121 UR - https://doi.org/10.1172/JCI45416 DO - 10.1172/JCI45416 ID - Kastenmuller2011 ER - TY - JOUR AU - Ahonen, C. L. AU - Doxsee, C. L. AU - McGurran, S. M. AU - Riter, T. R. AU - Wade, W. F. AU - Barth, R. J. PY - 2004 DA - 2004// TI - Combined TLR and CD40 triggering induces potent CD8 + T cell expansion with variable dependence on type I IFN JO - J Exp Med VL - 199 UR - https://doi.org/10.1084/jem.20031591 DO - 10.1084/jem.20031591 ID - Ahonen2004 ER - TY - JOUR AU - Ma, R. AU - Du, J. L. AU - Huang, J. AU - Wu, C. Y. PY - 2007 DA - 2007// TI - Additive effects of CpG ODN and R-848 as adjuvants on augmenting immune responses to HBsAg vaccination JO - Biochem Biophys Res Commun VL - 361 UR - https://doi.org/10.1016/j.bbrc.2007.07.028 DO - 10.1016/j.bbrc.2007.07.028 ID - Ma2007 ER - TY - JOUR AU - Shukla, N. M. AU - Salunke, D. B. AU - Balakrishna, R. AU - Mutz, C. A. AU - Malladi, S. S. AU - David, S. A. PY - 2012 DA - 2012// TI - Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0043612 DO - 10.1371/journal.pone.0043612 ID - Shukla2012 ER - TY - JOUR AU - Lu, D. AU - Liu, J. X. AU - Endo, T. AU - Zhou, H. AU - Yao, S. AU - Willert, K. PY - 2009 DA - 2009// TI - Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway JO - PLoS ONE VL - 4 UR - https://doi.org/10.1371/journal.pone.0008294 DO - 10.1371/journal.pone.0008294 ID - Lu2009 ER - TY - JOUR AU - Jackson, P. A. AU - Widen, J. C. AU - Harki, D. A. AU - Brummond, K. M. PY - 2016 DA - 2016// TI - Covalent modifiers: a chemical perspective on the reactivity of α, β-unsaturated carbonyls with thiols via hetero-michael addition reactions JO - J Med Chem VL - 60 UR - https://doi.org/10.1021/acs.jmedchem.6b00788 DO - 10.1021/acs.jmedchem.6b00788 ID - Jackson2016 ER - TY - JOUR AU - Kagan, J. C. AU - Su, T. AU - Horng, T. AU - Chow, A. AU - Akira, S. AU - Medzhitov, R. PY - 2008 DA - 2008// TI - TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta JO - Nat Immunol VL - 9 UR - https://doi.org/10.1038/ni1569 DO - 10.1038/ni1569 ID - Kagan2008 ER - TY - JOUR AU - Vasilakos, J. P. AU - Smith, R. M. AU - Gibson, S. J. AU - Lindh, J. M. AU - Pederson, L. K. AU - Reiter, M. J. PY - 2000 DA - 2000// TI - Adjuvant activities of immune response modifier R-848: comparison with CpG ODN JO - Cell Immunol VL - 204 UR - https://doi.org/10.1006/cimm.2000.1689 DO - 10.1006/cimm.2000.1689 ID - Vasilakos2000 ER - TY - JOUR AU - Birmachu, W. AU - Gleason, R. M. AU - Bulbulian, B. J. AU - Riter, C. L. AU - Vasilakos, J. P. AU - Lipson, K. E. PY - 2007 DA - 2007// TI - Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists JO - BMC immunology. VL - 8 UR - https://doi.org/10.1186/1471-2172-8-26 DO - 10.1186/1471-2172-8-26 ID - Birmachu2007 ER - TY - JOUR AU - Wu, T. Y. AU - Singh, M. AU - Miller, A. T. AU - Gregorio, E. AU - Doro, F. AU - D’Oro, U. PY - 2014 DA - 2014// TI - Rational design of small molecules as vaccine adjuvants JO - Sci Transl Med. VL - 6 UR - https://doi.org/10.1126/scitranslmed.3009980 DO - 10.1126/scitranslmed.3009980 ID - Wu2014 ER - TY - JOUR AU - Cortez, A. AU - Li, Y. AU - Miller, A. T. AU - Zhang, X. AU - Yue, K. AU - Maginnis, J. PY - 2016 DA - 2016// TI - Incorporation of phosphonate into benzonaphthyridine Toll-like receptor 7 agonists for adsorption to aluminum hydroxide JO - J Med Chem. VL - 59 UR - https://doi.org/10.1021/acs.jmedchem.6b00489 DO - 10.1021/acs.jmedchem.6b00489 ID - Cortez2016 ER - TY - JOUR AU - Mancini, F. AU - Monaci, E. AU - Lofano, G. AU - Torre, A. AU - Bacconi, M. AU - Tavarini, S. PY - 2016 DA - 2016// TI - One dose of Staphylococcus aureus 4C-staph vaccine formulated with a novel TLR7-dependent adjuvant rapidly protects mice through antibodies, effector CD4+ T cells, and IL-17A JO - PloS ONE. VL - 11 UR - https://doi.org/10.1371/journal.pone.0147767 DO - 10.1371/journal.pone.0147767 ID - Mancini2016 ER -